Rapport Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Rapport Therapeutics shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $219k | 9.4k | 23.30 |